1篇
您的检索式：作者名="Rojin Chegini"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade显示文摘Since December 2019,a novel coronavirus that represents a serious threat to human lives has emerged.There is still no definite treatment for severe cases of the disease caused by this virus,named coronavirus disease 2019(COVID-19).One of the most considered treatment strategies targets the exaggerated immune regulator,and interleukin(IL)-6 is a crucial pro-inflammatory mediator.Severe acute respiratory syndrome coronavirus 2(SARSCoV-2)cases show an elevated level of IL-6 related to disease severity.IL-6 activity can be inhibited by the following:IL-6 itself,IL-6 signaling pathways such as Janus kinase and signal transducer and activator of transcription(JAK-STAT),gp130,IL-6R,and downstream activated ILs,such as IL-17 and IL-6 cytokine.Currently,according to these studies and their results,IL-6 blockade with anti-IL-6 or its receptor antibodies such as tocilizumab in COVID-19 is beneficial in severe cases and may reduce the mortality rate.JAK-STAT inhibitors block the cytokine storm by inhibiting several crucial pro-inflammatory mediators such as TNF-αand IL-6 and have shown various results in clinical trials.IL-6 induces IL-17 secretion,and IL-17 is involved in the pathogenesis of inflammatory processes.Clinical trials of anti-IL-17 drugs are currently recruiting,and anti-gp130 antibody is preclinical.However,this agent has shown positive effects in inflammatory bowel disease clinical trials and could be tested for SARS-CoV-2.This study aimed to review the role of IL-6 in the cytokine storm and studies regarding IL-6 and blockade of its inflammatory pathways in COVID-19 to determine if any of these agents are beneficial for COVID-19 patients. | Mohaddeseh Bahmani Rojin Chegini Elham Ghanbari Elham Sheykhsaran Parisa Shiri Aghbash HamedEbrahimzadeh Leylabadlo Ehsan Moradian Amir Masoud Kazemzadeh Houjaghan Hossein Bannazadeh Baghi | 2022 | World Journal of Virology2022，11，3： | 2 |
您所在的机构暂未开通此部分的功能，请联系管理员